Jim Simons acquired 1.38 Million Supernus Pharmaceuticals shares worth $40 Million. That's 0.06% of their equity portfolio (362nd largest holding). The investor owns 2.28% of the outstanding Supernus Pharmaceuticals stock. The first Supernus Pharmaceuticals trade was made in Q3 2014. Since then Jim Simons bought shares fifteen more times and sold shares on fifteen occasions. The investor's estimated purchase price is $45.9 Million, resulting in a loss of 13%.